National Commission on COVID-19 Act

Summary

National Commission on COVID-19 Act This bill establishes the National Commission on COVID-19 (i.e., coronavirus disease 2019) in the legislative branch to assess the emergence, spread, and response to the disease in the United States and sets forth its powers, duties, funding, and membership. The commission must issue a report with findings and recommendations concerning, among other topics, surveillance, testing, treatment, and vaccines; medical devices, drugs, and other supplies, including personal protective equipment; preparedness and capacity of the U.S. health care system; certain federal laws and programs such as the Defense Production Act, the Strategic National Stockpile, and others; public health measures such as social distancing; and roles and responsibilities among federal departments, as well as coordination and communication between those departments and other entities, including state, territorial, tribal, and local governments. The commission terminates 60 days after the submission of the final report.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 3 April 2020

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 3 April 2020

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 3 April 2020

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.